Is CVE-2022-26389 in the CISA KEV catalog?

No. CVE-2022-26389 is not currently on the CISA Known Exploited Vulnerabilities list.

What is the CVSS severity of CVE-2022-26389?

CVE-2022-26389 has a CVSS v3 base score of 7.7 (HIGH).

What is the EPSS score for CVE-2022-26389?

CVE-2022-26389 has an EPSS score of 0.27% (19th percentile), estimating the probability of exploitation in the next 30 days.

CVE & CISA-KEV Catalog

CVE-2022-26389

HIGH

7.7

CVSS v3

NVD

Description

An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.

CWE-284Improper Access Control

CVSS v3 Vector

Exploitability

Attack VectorNetwork

Attack ComplexityHigh

Privileges RequiredLow

User InteractionNone

ScopeChanged

Impact

ConfidentialityLow

IntegrityLow

AvailabilityHigh

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H

Exploit Intelligence

0.27%probability of exploitation in 30 days

19thpercentile

Low risk: more likely to be exploited than 19% of all known CVEs.

References

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2025-02-07.